183 related articles for article (PubMed ID: 36991180)
1. De novo drug design based on Stack-RNN with multi-objective reward-weighted sum and reinforcement learning.
Hu P; Zou J; Yu J; Shi S
J Mol Model; 2023 Mar; 29(4):121. PubMed ID: 36991180
[TBL] [Abstract][Full Text] [Related]
2. MoleGuLAR: Molecule Generation Using Reinforcement Learning with Alternating Rewards.
Goel M; Raghunathan S; Laghuvarapu S; Priyakumar UD
J Chem Inf Model; 2021 Dec; 61(12):5815-5826. PubMed ID: 34866384
[TBL] [Abstract][Full Text] [Related]
3. Memory augmented recurrent neural networks for de-novo drug design.
Suresh N; Chinnakonda Ashok Kumar N; Subramanian S; Srinivasa G
PLoS One; 2022; 17(6):e0269461. PubMed ID: 35737661
[TBL] [Abstract][Full Text] [Related]
4. Multiobjective de novo drug design with recurrent neural networks and nondominated sorting.
Yasonik J
J Cheminform; 2020 Feb; 12(1):14. PubMed ID: 33430996
[TBL] [Abstract][Full Text] [Related]
5. Faster and more diverse de novo molecular optimization with double-loop reinforcement learning using augmented SMILES.
Bjerrum EJ; Margreitter C; Blaschke T; Kolarova S; de Castro RL
J Comput Aided Mol Des; 2023 Aug; 37(8):373-394. PubMed ID: 37329395
[TBL] [Abstract][Full Text] [Related]
6. Magicmol: a light-weighted pipeline for drug-like molecule evolution and quick chemical space exploration.
Chen L; Shen Q; Lou J
BMC Bioinformatics; 2023 Apr; 24(1):173. PubMed ID: 37101113
[TBL] [Abstract][Full Text] [Related]
7. FSM-DDTR: End-to-end feedback strategy for multi-objective De Novo drug design using transformers.
Monteiro NRC; Pereira TO; Machado ACD; Oliveira JL; Abbasi M; Arrais JP
Comput Biol Med; 2023 Sep; 164():107285. PubMed ID: 37557054
[TBL] [Abstract][Full Text] [Related]
8. Deep learning for molecular generation.
Xu Y; Lin K; Wang S; Wang L; Cai C; Song C; Lai L; Pei J
Future Med Chem; 2019 Mar; 11(6):567-597. PubMed ID: 30698019
[TBL] [Abstract][Full Text] [Related]
9. DrugEx v2: de novo design of drug molecules by Pareto-based multi-objective reinforcement learning in polypharmacology.
Liu X; Ye K; van Vlijmen HWT; Emmerich MTM; IJzerman AP; van Westen GJP
J Cheminform; 2021 Nov; 13(1):85. PubMed ID: 34772471
[TBL] [Abstract][Full Text] [Related]
10. Scaffold-Constrained Molecular Generation.
Langevin M; Minoux H; Levesque M; Bianciotto M
J Chem Inf Model; 2020 Dec; 60(12):5637-5646. PubMed ID: 33301333
[TBL] [Abstract][Full Text] [Related]
11. De novo drug design as GPT language modeling: large chemistry models with supervised and reinforcement learning.
Ye G
J Comput Aided Mol Des; 2024 Apr; 38(1):20. PubMed ID: 38647700
[TBL] [Abstract][Full Text] [Related]
12. Deep Reinforcement Learning for Multiparameter Optimization in
Ståhl N; Falkman G; Karlsson A; Mathiason G; Boström J
J Chem Inf Model; 2019 Jul; 59(7):3166-3176. PubMed ID: 31273995
[TBL] [Abstract][Full Text] [Related]
13. Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?
D'Souza S; Kv P; Balaji S
Expert Opin Drug Discov; 2022 Oct; 17(10):1071-1079. PubMed ID: 36216812
[TBL] [Abstract][Full Text] [Related]
14. Augmented Hill-Climb increases reinforcement learning efficiency for language-based de novo molecule generation.
Thomas M; O'Boyle NM; Bender A; de Graaf C
J Cheminform; 2022 Oct; 14(1):68. PubMed ID: 36192789
[TBL] [Abstract][Full Text] [Related]
15. Generative machine learning for de novo drug discovery: A systematic review.
Martinelli DD
Comput Biol Med; 2022 Jun; 145():105403. PubMed ID: 35339849
[TBL] [Abstract][Full Text] [Related]
16. Generative Recurrent Networks for De Novo Drug Design.
Gupta A; Müller AT; Huisman BJH; Fuchs JA; Schneider P; Schneider G
Mol Inform; 2018 Jan; 37(1-2):. PubMed ID: 29095571
[TBL] [Abstract][Full Text] [Related]
17. GRELinker: A Graph-Based Generative Model for Molecular Linker Design with Reinforcement and Curriculum Learning.
Zhang H; Huang J; Xie J; Huang W; Yang Y; Xu M; Lei J; Chen H
J Chem Inf Model; 2024 Feb; 64(3):666-676. PubMed ID: 38241022
[TBL] [Abstract][Full Text] [Related]
18. Generative Deep Learning for Targeted Compound Design.
Sousa T; Correia J; Pereira V; Rocha M
J Chem Inf Model; 2021 Nov; 61(11):5343-5361. PubMed ID: 34699719
[TBL] [Abstract][Full Text] [Related]
19. Molecular substructure tree generative model for de novo drug design.
Wang S; Song T; Zhang S; Jiang M; Wei Z; Li Z
Brief Bioinform; 2022 Mar; 23(2):. PubMed ID: 35039853
[TBL] [Abstract][Full Text] [Related]
20. De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment.
Fang Y; Pan X; Shen HB
Bioinformatics; 2023 Apr; 39(4):. PubMed ID: 36961341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
